1. HOME
2. Research Insight
3. Abbott Laboratories, Inc. (US) and Medtronic plc (Ireland) are Leading players in the Patient Monitoring Devices Market

The patient monitoring devices market is projected to reach USD 71.1 billion by 2029 from USD 48.5 billion in 2024, growing at a CAGR of 8.0% during the forecast period. Growth in the patient monitoring market is mainly due to an increase in demand for biosensors, remote patient monitoring,  Growing investments and patient benefits such as early detection of disease for treatment.

The patient monitoring devices market is characterized by a moderate level of competition, with some well-established players holding a significant market share. The market is more competitive because of the increased funding for chronic disease and the rise in advance patient monitoring solutions brought by higher R&D expenditures. Here are some of the key players in the patient monitoring market: Medtronic plc (Ireland), Abbott Laboratories, Inc. (US), GE Healthcare (US), Nihon Kohden Corporation (Japan), and Mindray Medical International. (China), Boston Scientific Corporation (US) are of the prominent companies in the patient monitoring market.

To know about the assumptions considered for the study download the pdf brochure

Abbott Laboratories (US): Abbott's cardiac rhythm management and diabetes business segment provides patient monitoring solutions. Abbott offers a range of insertable cardiac monitors (ICMs) like Confirm Rx™ and Assert-IQ™ for continuous heart rhythm monitoring. These minimally invasive devices help detect arrhythmias and improve patient outcomes. Abbott's hemodynamic monitoring systems provide healthcare professionals with crucial real-time data on vital signs, allowing them to closely monitor and optimize care for critically ill patients. Abbott's unwavering commitment to innovation and patient-centric solutions positions them as a frontrunner in the evolving patient monitoring market. As healthcare models shift towards value-based care and remote monitoring becomes increasingly critical, Abbott is well-positioned to capitalize on this growth trajectory through the development of next-generation patient monitoring technologies.

Medtronic plc (Ireland): Medtronic boasts a robust portfolio of cardiac monitoring solutions. This includes Holter monitors for extended ECG recording, implantable telemetry systems for real-time wireless data transmission, and hemodynamic monitoring systems critical for intensive care environments. Medtronic caters to neurological monitoring needs with EEG systems for monitoring brain activity during surgeries and critical care. Additionally, their cerebral oximeters offer valuable insights into brain tissue oxygen saturation levels. Recognizing the growing importance of remote care, it provides platforms and tools that empower patients with chronic conditions to manage their health from home. This fosters improved care coordination and continuity between patients and healthcare providers.

GE Healthcare (US): GE Healthcare, a longstanding leader in medical technology,  brings a rich heritage to the patient monitoring market. It offers a comprehensive suite of bedside monitors catering to diverse patient needs. These systems range from basic vital sign monitoring to advanced hemodynamic and respiratory parameter tracking, ensuring adaptability across care settings. Additionally, seamless integration with hospital networks facilitates efficient data management. ecognizing the critical role of data flow, GE Healthcare prioritizes robust connectivity. Their solutions ensure seamless integration of monitoring devices with electronic health records (EHR) systems and broader healthcare IT infrastructure. This centralized data management empowers informed clinical decision-making. GE Healthcare's legacy in patient monitoring, coupled with their commitment to innovation and a strategic focus on value-based care, positions them for continued success. As the industry embraces AI-powered analytics, remote monitoring solutions, and wearable biosensors, GE Healthcare is well-positioned to remain a key player in shaping the future of patient monitoring.

Nihon Kohden Corporation (Japan): Nihon Kohden boasts a wide range of bedside monitors catering to various healthcare environments. From basic vital sign monitoring for general wards to advanced hemodynamic and respiratory parameter tracking for intensive care units (ICUs), their systems deliver optimal monitoring capabilities across the care continuum. Nihon Kohden remains at the forefront of developing advanced patient monitoring technologies. Key areas of focus include: They actively integrate artificial intelligence (AI) for real-time data analysis and anomaly detection. This holds the potential for earlier intervention and improved patient outcomes., and Nihon Kohden develops solutions that seamlessly integrate patient monitoring data with telemedicine platforms. This allows for remote consultations and specialist intervention when needed, fostering a more flexible and accessible care delivery model.

Philips Healthcare (Netherlands): Philips boasts a robust portfolio of bedside monitors catering to various acuity levels. From basic vital sign monitoring to advanced hemodynamic and respiratory parameter tracking (IntelliVue, Efficia, and Goldway monitors), their systems offer optimal adaptability across diverse clinical settings. Philips offers continuous monitoring solutions like the IntelliVue Guardian monitor. This monitor allows for uninterrupted monitoring of vital signs during patient transport and transitions between care areas, reducing the risk of data gaps and enhancing patient safety.

Related Reports:

Patient Monitoring Devices Market by Product (Cardiac monitoring devices, Pulse Oximeter, Spirometer, Fetal Monitor, Temperature Monitor, blood pressure monitors, ECG, ICP, weight Monitoring), User, Customer Unmet Needs- Global Forec ast to 2029

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]